Human medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 25, Status: Authorised

Submitted by Anonymous (not verified) on 23 June 2025 - 16:15

Human medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Entresto, sacubitril,valsartan, Date of authorisation: 19/11/2015, Revision: 25, Status: Authorised

Submitted by Anonymous (not verified) on 23 June 2025 - 16:05

Human medicines European public assessment report (EPAR): Entresto, sacubitril,valsartan, Date of authorisation: 19/11/2015, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 15, Status: Authorised

Submitted by Anonymous (not verified) on 23 June 2025 - 15:33

Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 15, Status: Authorised

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - November 2025, Online, from 19 November 2025, 14:00 (CET) to 21 November 2025, 18:30 (CET)

Submitted by Anonymous (not verified) on 23 June 2025 - 14:27

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - November 2025, Online, from 19 November 2025, 14:00 (CET) to 21 November 2025, 18:30 (CET)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More